Мақаланы E-mail арқылы жіберу Simultaneous Determination of Metoprolol and Bisoprolol in Human Serum by HPLC-MS/MS for Clinical Drug Monitoring
- Авторлар: Rodina T.A.1,2, Mel’nikov E.S.2,3, Dmitriev A.I.2,3, Belkov S.A.1,2,3, Sokolov A.V.1,3, Arkhipov V.V.1,3, Prokof’ev A.B.1,2,3
-
Мекемелер:
- Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
- I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
- 3I. M. Sechenov First Moscow State Medical University
- Шығарылым: Том 51, № 12 (2018)
- Беттер: 1111-1118
- Бөлім: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244934
- DOI: https://doi.org/10.1007/s11094-018-1750-4
- ID: 244934
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
A method for simultaneous determination of metoprolol and bisoprolol in human blood serum by HPLC-MS/MS was developed and validated. The analytical ranges of the method were 5 – 250 ng/mL and 1 – 250 ng/mL for metoprolol and bisoprolol, respectively. The suitability of the developed for therapeutic drug monitoring during treatment for arterial hypertension and other cardiovascular diseases was demonstrated. In particular, the proposed method could identify patients at high risk for developing adverse effects and help to monitor a switch between metoprolol and bisoprolol while changing the pharmacotherapy regime.
Негізгі сөздер
Авторлар туралы
T. Rodina
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240
E. Mel’nikov
I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
Ресей, 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
A. Dmitriev
I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
Ресей, 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
S. Belkov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
A. Sokolov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
V. Arkhipov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
A. Prokof’ev
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health; 3I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 11 Yauzskaya St., Moscow, 109240; 8/2 Trubetskaya St., Moscow, 119991
Қосымша файлдар
